These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 2234508
1. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Kavaliers M. Neurosci Lett; 1990 Jul 31; 115(2-3):307-12. PubMed ID: 2234508 [Abstract] [Full Text] [Related]
2. Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice. Kavaliers M, Yang HY. Peptides; 1991 Jul 31; 12(2):235-9. PubMed ID: 2067975 [Abstract] [Full Text] [Related]
3. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice. Kavaliers M, Yang HY. Peptides; 1989 Jul 31; 10(4):741-5. PubMed ID: 2587416 [Abstract] [Full Text] [Related]
4. A-18-famide and F-8-famide, endogenous mammalian equivalents of the molluscan neuropeptide FMRFamide (Phe-Met-Arg-Phe-NH2), inhibit colonic bead expulsion time in mice. Raffa RB, Jacoby HI. Peptides; 1989 Jul 31; 10(4):873-5. PubMed ID: 2587427 [Abstract] [Full Text] [Related]
5. Neuropeptide FF, pain and analgesia. Roumy M, Zajac JM. Eur J Pharmacol; 1998 Mar 12; 345(1):1-11. PubMed ID: 9593588 [Abstract] [Full Text] [Related]
6. Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and activity. Kavaliers M, Hirst M. Brain Res; 1986 May 07; 372(2):370-4. PubMed ID: 2871903 [Abstract] [Full Text] [Related]
7. Calcium channel blockers inhibit the antagonistic effects of Phe-Met-Arg-Phe-amide (FMRFamide) on morphine- and stress-induced analgesia in mice. Kavaliers M. Brain Res; 1987 Jul 14; 415(2):380-4. PubMed ID: 2440527 [Abstract] [Full Text] [Related]
8. Modulation of human lymphocyte proliferation by FLFQPQRFamide, a FMRFamide-like peptide with anti-opiate properties. Lecron JC, Minault M, Allard M, Goube de Laforest P, Gombert J, Simonnet G. J Neuroimmunol; 1992 May 14; 38(1-2):1-8. PubMed ID: 1577948 [Abstract] [Full Text] [Related]
9. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors. Raffa RB, Kim A, Rice KC, de Costa BR, Codd EE, Rothman RB. Peptides; 1994 May 14; 15(3):401-4. PubMed ID: 7937312 [Abstract] [Full Text] [Related]
10. Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats. Kivipelto L, Majane EA, Yang HY, Panula P. J Comp Neurol; 1989 Aug 08; 286(2):269-87. PubMed ID: 2794121 [Abstract] [Full Text] [Related]
11. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Kavaliers M, Innes D. Peptides; 1992 Aug 08; 13(3):603-7. PubMed ID: 1523172 [Abstract] [Full Text] [Related]
12. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Gouardères C, Sutak M, Zajac JM, Jhamandas K. Eur J Pharmacol; 1993 Jun 11; 237(1):73-81. PubMed ID: 8102975 [Abstract] [Full Text] [Related]
13. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Yang HY, Fratta W, Majane EA, Costa E. Proc Natl Acad Sci U S A; 1985 Nov 11; 82(22):7757-61. PubMed ID: 3865193 [Abstract] [Full Text] [Related]
14. Neuropeptides Gly-Asp-Pro-Phe-Leu-Arg-Phe-amide (GDPFLRFamide) and Ser-Asp-Pro-Phe-Leu-Arg-Phe-amide (SDPFLRFamide) are encoded by an exon 3' to Phe-Met-Arg-Phe-NH2 (FMRFamide) in the snail Lymnaea stagnalis. Saunders SE, Bright K, Kellett E, Benjamin PR, Burke JF. J Neurosci; 1991 Mar 11; 11(3):740-5. PubMed ID: 2002360 [Abstract] [Full Text] [Related]
15. Eight novel FMRFamide-like neuropeptides isolated from the nematode Ascaris suum. Cowden C, Stretton AO. Peptides; 1995 Mar 11; 16(3):491-500. PubMed ID: 7651904 [Abstract] [Full Text] [Related]
16. FMRFamide: an endogenous peptide with marked inhibitory effects on opioid-induced feeding behavior. Kavaliers M, Hirst M. Brain Res Bull; 1986 Sep 11; 17(3):403-8. PubMed ID: 3533222 [Abstract] [Full Text] [Related]
17. FMRFamide, a putative endogenous opiate antagonist: evidence from suppression of defeat-induced analgesia and feeding in mice. Kavaliers M, Hirst M. Neuropeptides; 1985 Dec 11; 6(6):485-94. PubMed ID: 4080110 [Abstract] [Full Text] [Related]
18. The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice. Jacoby MB, Jacoby HI, Mathiasen JR, Raffa RB. Neurosci Lett; 1987 Dec 16; 83(1-2):128-32. PubMed ID: 3441291 [Abstract] [Full Text] [Related]
19. Effect of Phe-D-Met-Arg-Phe-NH2 and other Phe-Met-Arg-Phe-NH2-related peptides on mouse colonic propulsive motility: a structure-activity relationship study. Raffa RB, Jacoby HI. J Pharmacol Exp Ther; 1990 Sep 16; 254(3):809-14. PubMed ID: 1975622 [Abstract] [Full Text] [Related]
20. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. Million M, Fioramonti J, Gicquel S, Zajac JM, Bueno L. J Pharmacol Exp Ther; 1993 Apr 16; 265(1):96-102. PubMed ID: 8474035 [Abstract] [Full Text] [Related] Page: [Next] [New Search]